Storys zum Thema Health

Medison Pharma; Ipsen

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Zug, Switzerland and Paris (ots/PRNewswire) - Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, ...

Antech Diagnostics

Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory

Warwick, England, 7 Nov. 2023 (ots/PRNewswire) - Antech to offer UK veterinary professionals a complete and flexible diagnostics portfolio spanning reference labs, in-house diagnostics, imaging and software Antech, the full-service veterinary diagnostics business that is part of the Science & Diagnostics division of ...

Soterios Pharma

Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata

London (ots/PRNewswire) - Soterios Pharma, a privately held clinical-stage pharmaceutical company, announced today that it has completed target enrolment for its Phase II trial with STS-01 for mild / moderate (patchy) alopecia areata. Final results of the study are anticipated to be available in Q2 2024. David Fleet, CEO of Soterios Pharma, said, "This represents an ...

APRIL Group

APRIL International strengthens its presence in Europe with the acquisition of Expat & Co in Belgium

Lyon, France and Paris (ots/PRNewswire) - APRIL Group, Europe's leading wholesale insurance broker, announces the acquisition of Expat & Co, a specialist in international health insurance in Belgium. Expat & Co is the leading independent underwriter of insurance for expatriates in Belgium and offers a platform of ...

Acousia Therapeutics GmbH

Hearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial

Tübingen, Germany (ots/PRNewswire) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic ...

European Academy of Allergy and Clinical Immunology

EAACI International Severe Asthma Forum (ISAF) Hybrid 2023: Advancing Severe Asthma Care

Zurich (ots/PRNewswire) - The Organising Committee of the EAACI International Severe Asthma Forum (ISAF) is pleased to announce the upcoming ISAF Hybrid 2023 event, scheduled to take place in the historic city of Rome from October 05 to October 07, 2023. This event will unite global experts and emerging professionals to address the challenges of severe asthma and ...

SwissFinTechLadies

What changes when we fulfil the dream of living longer?

Takeda

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older

Zurich (ots/PRNewswire) - - If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. - Positive Opinion Based on Pivotal Study SHP643-301, Evaluating the Safety Profile and Pharmacokinetics (PK) of Lanadelumab, in Combination with ...

Silony Medical International AG

Silony Medical acquires Centinel Spine's Global Fusion Business

Frauenfeld, Switzerland (ots/PRNewswire) - The transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform Silony Medical International AG (the company), a growing challenger to "big medtech" in the global spinal fusion market, has signed a definitive agreement to acquire Centinel Spine's Global Fusion Business. This combines Silony's Verticale® posterior screw & rod fusion ...

MAVERICKS Life Co.

Latest Sports & Fitness Innovation: Holistic Training Syllabus by MAVERICKS Life Co.

CRANS-MONTANA, Switzerland (ots/PRNewswire) - Sports science & wellbeing education company, MAVERICKS Life Co., announces the release of its new Holistic Training Syllabus, rooted in evolutionary biology and epigenetics theory. It's a brand new innovation in the sports and fitness sector. Recent scientific studies* have led to groundbreaking development that is ...

BioData

Labguru (BioData) Partners with SAP to Provide its Lab Data Management Solution via the SAP Store

Boston (ots/PRNewswire) - BioData today revealed that Labguru, its all-encompassing Lab Data Management solution, is now accessible on SAP® Store, the digital marketplace for SAP and Software Partner Providers. The addition to the SAP store will increase the ease with which customers can access Labguru, ensuring ...

Norgine GmbH

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

Amsterdam (ots/PRNewswire) - Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment of Saulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience and a unique blend of ...

Isotopia Molecular Imaging

Isotopia Issues a call to action to the radionuclide Therapy industry.

Petah Tikva, Israel (ots/PRNewswire) - Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes therapeutic and diagnostic radioactive isotopes. "If you are in the Lu-177 field, don't miss this information." The Lu-177 radiopharmaceuticals sector stands at a critical juncture, necessitating urgent collaboration. Our shared ...

WS Audiology

Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise

Lynge, Denmark (ots/PRNewswire) - Hearing aid innovator Signia, part of WS Audiology, today launches Integrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns their head, the hearing aids ...

COP28 UAE

COP28 Presidency urges adaptation efforts at Korea Global Adaptation Week

Incheon, South Korea (ots/PRNewswire) - - Ambassador Majid Al Suwaidi, Director-General and Special Representative of COP28, stressed the urgency of delivering a robust Framework on the Global Goal on Adaptation - He reiterated the call for developed countries to uphold their commitment to doubling adaptation finance by 2025. - The Global Stocktake at COP28 will enable ...

Johnson & Johnson Vision

Johnson & Johnson Vision announces launch of ELITA™ Platform to Correct Myopia with New SILK Procedure at the European Society of Cataract and Refractive Surgeons Congress

London (ots/PRNewswire) - Next-generation laser vision correction provides next-day results and recovery1,2 - The next-generation ELITATM Femtosecond Laser to correct myopia with the new SILK procedure** - The latest innovation in extended depth of focus (EDOF) intraocular lenses (IOLs) will be shared with invited ...

HUMA Therapeutics

Huma collaborates with Google Cloud to improve healthcare through generative AI

New York (ots/PRNewswire) - - Huma aims to further support patients and the healthcare workforce by enhancing its regulated Software as Medical Device (SaMD) platform with the addition of generative AI applications - Huma is leveraging Google Cloud's Vertex AI platform and exploring the use of other Google GenAI tools such as Med-PaLM 2 - Huma and Google Cloud are ...

Aurisco Pharmaceutical

Successful FDA inspection at Aurisco's manufacturing site in Yangzhou, China

Yangzhou, China (ots/PRNewswire) - Aurisco Pharmaceutical today announced that its cGMP manufacturing plant in Yangzhou has successfully passed a USFDA inspection. Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA). The inspection, carried out by ...

CartiHeal

CartiHeal Announces First Commercial Implantation of Agili-C™ in the US

Kfar Saba, Israel (ots/PRNewswire) - CartiHeal Ltd., developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced its first commercial implantation of Agili-C in the US by Dr. Ken Zaslav, a specialist in Orthopedic Surgery and Sports Medicine at Northwell Health in New York City, NY. The ...

ProductLife Group (PLG)

PRODUCTLIFE GROUP ACQUIRES RNI, EXPANDING ITS SCIENTIFIC AND REGULATORY OFFERING TO SELFCARE PRODUCTS

Paris (ots/PRNewswire) - ProductLife Group, a global provider of regulatory and compliance services for the life sciences industry, strengthens its regulatory expertise in borderline products with the acquisition of RNI, a consulting firm providing global regulatory and scientific services across the entire spectrum ...

D&A Pharma

D&A Pharma : Despite the latest alarming figures on alcohol dependence, France is delaying the use of sodium oxybate, which has been prescribed for almost 30 years in Italy and Austria

Paris (ots/PRNewswire) - At the beginning of June, the health authorities hammered it home once again: "The health, social and economic consequences of alcohol consumption represent a burden for French society." The results are alarming: every year in France, alcohol is the cause of 49,000 deaths and an estimated ...

REVEAL GENOMICS, S.L.

REVEAL GENOMICS® ANNOUNCES POSITIVE TOP-LINE RESULTS FOR HER2DX® IN MEDSIR'S PHERGAIN TRIAL

Barcelona, Spain (ots/PRNewswire) - - HER2DX® pCR-score was significantly associated with pathological complete response in patients with HER2+ breast cancer treated with trastuzumab and pertuzumab, with or without chemotherapy. - HER2DX® risk-score identified 85% of patients with an invasive disease event as ...

CROMA-PHARMA GmbH

Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China

Vienna (ots/PRNewswire) - Croma-Pharma® ('Croma') announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 in China. The randomised, multi-centre, evaluator blinded, parallel group, active ...

HUMA Therapeutics

Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform

New York and London (ots/PRNewswire) - - Class II clearance expands the patient population that can be managed - Companies working with Huma's platform can now launch algorithm innovations more quickly in a compliant and de-risked manner, democratising digital health innovation across the industry - Clearance was ...